BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 22706618)

  • 1. Underreporting in pharmacovigilance: an intervention for Italian GPs (Emilia-Romagna region).
    Biagi C; Montanaro N; Buccellato E; Roberto G; Vaccheri A; Motola D
    Eur J Clin Pharmacol; 2013 Feb; 69(2):237-44. PubMed ID: 22706618
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of pharmacist involvement on patient reporting of adverse drug reactions: first Italian study.
    Leone R; Moretti U; D'Incau P; Conforti A; Magro L; Lora R; Velo G
    Drug Saf; 2013 Apr; 36(4):267-76. PubMed ID: 23475583
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Are consumers ready to take part in the Pharmacovigilance System?--a Portuguese preliminary study concerning ADR reporting.
    Matos C; van Hunsel F; Joaquim J
    Eur J Clin Pharmacol; 2015 Jul; 71(7):883-90. PubMed ID: 26004569
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Completeness of Spontaneous Adverse Drug Reaction Reports Sent by General Practitioners to a Regional Pharmacovigilance Centre: A Descriptive Study.
    Durrieu G; Jacquot J; Mège M; Bondon-Guitton E; Rousseau V; Montastruc F; Montastruc JL
    Drug Saf; 2016 Dec; 39(12):1189-1195. PubMed ID: 27688025
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reporting, handling, and subjective importance of adverse drug reactions among general practitioners: an exploratory cross-sectional survey.
    Gahr M; Connemann B; Zeiss R; Schönfeldt-Lecuona C; Dreyhaupt J; Lazik C
    Expert Opin Drug Saf; 2021 Aug; 20(8):979-985. PubMed ID: 34014779
    [No Abstract]   [Full Text] [Related]  

  • 6. Knowledge, attitude and practice of General Practitioners towards adverse drug reaction reporting in South of Iran, Shiraz (Pharmacoepidemiology report).
    Peymani P; Tabrizi R; Afifi S; Namazi S; Heydari ST; Shirazi MK; Nouraei H; Sadeghi E; Lankarani KB; Maharlouei N
    Int J Risk Saf Med; 2016 Mar; 28(1):25-31. PubMed ID: 27176754
    [TBL] [Abstract][Full Text] [Related]  

  • 7. First French experience of ADR reporting by patients after a mass immunization campaign with Influenza A (H1N1) pandemic vaccines: a comparison of reports submitted by patients and healthcare professionals.
    Durrieu G; Palmaro A; Pourcel L; Caillet C; Faucher A; Jacquet A; Ouaret S; Perault-Pochat MC; Kreft-Jais C; Castot A; Lapeyre-Mestre M; Montastruc JL;
    Drug Saf; 2012 Oct; 35(10):845-54. PubMed ID: 22967189
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of patient reporting of adverse drug reactions to the UK 'Yellow Card Scheme': literature review, descriptive and qualitative analyses, and questionnaire surveys.
    Avery AJ; Anderson C; Bond CM; Fortnum H; Gifford A; Hannaford PC; Hazell L; Krska J; Lee AJ; McLernon DJ; Murphy E; Shakir S; Watson MC
    Health Technol Assess; 2011 May; 15(20):1-234, iii-iv. PubMed ID: 21545758
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of a simplified pharmacovigilance tool for general practitioners: 5 years of insight.
    Trenque A; Rabiaza A; Fedrizzi S; Chretien B; Sassier M; Morello R; Alexandre J; Humbert X
    Sci Rep; 2024 Jan; 14(1):1766. PubMed ID: 38243051
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The contribution of Ghanaian patients to the reporting of adverse drug reactions: a quantitative and qualitative study.
    Jacobs TG; Hilda Ampadu H; Hoekman J; Dodoo ANO; Mantel-Teeuwisse AK
    BMC Public Health; 2018 Dec; 18(1):1384. PubMed ID: 30563498
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Under-reporting of adverse drug reactions: a challenge for pharmacovigilance in India.
    Tandon VR; Mahajan V; Khajuria V; Gillani Z
    Indian J Pharmacol; 2015; 47(1):65-71. PubMed ID: 25821314
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of information letters on the reporting rate of adverse drug reactions and the quality of the reports: a randomized controlled study.
    Johansson ML; Hägg S; Wallerstedt SM
    BMC Clin Pharmacol; 2011 Sep; 11():14. PubMed ID: 21899766
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Knowledge, attitudes, and perceptions of pharmacists to adverse drug reaction reporting in Iran.
    Vessal G; Mardani Z; Mollai M
    Pharm World Sci; 2009 Apr; 31(2):183-7. PubMed ID: 19116770
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effectiveness of pharmacovigilance training of general practitioners: a retrospective cohort study in the Netherlands comparing two methods.
    Gerritsen R; Faddegon H; Dijkers F; van Grootheest K; van Puijenbroek E
    Drug Saf; 2011 Sep; 34(9):755-62. PubMed ID: 21830837
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ten years of pharmacovigilance in Italy: the experience of Emilia-Romagna region in the monitoring of drug's safety profile.
    Motola D; Melis M; Lo Bianco S; Buccellato E; Biagi C; Vaccheri A
    Expert Opin Drug Saf; 2014 Jul; 13(7):867-73. PubMed ID: 24809453
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Workshop- and telephone-based interventions to improve adverse drug reaction reporting: a cluster-randomized trial in Portugal.
    Herdeiro MT; Ribeiro-Vaz I; Ferreira M; Polónia J; Falcão A; Figueiras A
    Drug Saf; 2012 Aug; 35(8):655-65. PubMed ID: 22788235
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reporting of adverse drug reactions by general practitioners: a questionnaire-based study in the Netherlands.
    Passier A; ten Napel M; van Grootheest K; van Puijenbroek E
    Drug Saf; 2009; 32(10):851-8. PubMed ID: 19722728
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of completeness of suspected adverse drug reaction reports submitted to the mexican national pharmacovigilance centre: a cross-sectional period-prevalence study.
    Sánchez-Sánchez B; Altagracia-Martínez M; Kravzov-Jinich J; Moreno-Bonett C; Vázquez-Moreno E; Martínez-Núñez JM
    Drug Saf; 2012 Oct; 35(10):837-44. PubMed ID: 22924896
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of e-mails containing ADR information and a current case report on ADR reporting rate and quality of reports.
    Johansson ML; Brunlöf G; Edward C; Wallerstedt SM
    Eur J Clin Pharmacol; 2009 May; 65(5):511-4. PubMed ID: 19127360
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Online reporting of adverse drug reactions: a study from a French regional pharmacovigilance center.
    Abadie D; Chebane L; Bert M; Durrieu G; Montastruc JL
    Therapie; 2014; 69(5):395-400. PubMed ID: 25269141
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.